- Home
- BCRX vs XPEL Comparison
BCRX vs XPEL Comparison
Compare BCRX & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCRX | XPEL |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | BCRX | XPEL |
|---|---|---|
| Price | $6.65 | $52.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $20.82 | N/A |
| AVG Volume (30 Days) | ★ 4.9M | 171.2K |
| Earning Date | 02-23-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.69 |
| Revenue | ★ $599,816,000.00 | $461,460,000.00 |
| Revenue This Year | $40.20 | $16.20 |
| Revenue Next Year | $6.36 | $11.28 |
| P/E Ratio | ★ N/A | $30.93 |
| Revenue Growth | ★ 45.38 | 10.29 |
| 52 Week Low | $6.00 | $24.25 |
| 52 Week High | $11.31 | $55.84 |
Technical Indicators
Market Signals| Indicator | BCRX | XPEL |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 49.79 |
| Support Level | $6.59 | $52.94 |
| Resistance Level | $7.15 | $55.84 |
| Average True Range (ATR) | 0.37 | 1.79 |
| MACD | -0.04 | -0.43 |
| Stochastic Oscillator | 12.34 | 4.06 |
Price Performance
Historical ComparisonAbout BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.